marijuana stocks news

Will Insys Therapeutics (INSY) Continue to Surge Higher? – Tale of the Tape

As of late, it has definitely been a great time to be an investor in Insys Therapeutics Inc (INSY). The stock has moved higher by 17.3% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider INSY’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as INSY has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.

 

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GW Pharmaceuticals plc (GWPH) to Present Epidiolex® (cannabidiol) Data at the American Epilepsy Society Annual Meeting

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Epidiolex® (cannabidiol) Data…

$NRTI Meets with Scientific/Medical Board To Plan for New CBD-Based Supplement Line

Inergetics’ Scientific/Medical Advisory Board Meets to Discuss Launch Preparations for its New…

GTEC Holdings Ltd. (GTEC.V) (GGTTF) Announces Supply Agreement with Namaste Technologies & Cannmart

GTEC Announces Supply Agreement with Namaste Technologies & Cannmart GTEC Holdings Ltd.…

Ayr Wellness Inc. (AYRWF) to Hold First Quarter 2022 Conference Call on May 26, 2022 at 8:30 a.m. ET

Ayr Wellness to Hold First Quarter 2022 Conference Call on May 26,…